Poltreg S.A.
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Poltreg S.A. is a clinical-stage biotechnology company pioneering the development of T-regulatory cell (Treg) therapies for autoimmune diseases. The company aims to establish Tregs as a new class of disease-modifying therapeutics. Its advanced pipeline features several clinical assets, with the lead candidate, PTG-007, being developed for Type-1 Diabetes and Multiple Sclerosis (MS). Poltreg is also advancing engineered cell therapies, including first-in-class CAR-Treg programs for MS and Amyotrophic Lateral Sclerosis (ALS). Leveraging its own manufacturing facilities and extensive experience, the company was the first to administer a Treg-based therapy to a patient.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-19 17:15 |
Regulatory News Service
Raport kwartalny 3Q 2025
|
Polish | 3.1 MB | ||
| 2025-11-10 13:17 |
Regulatory News Service
Przyznanie europejskiego patentu dotyczącego metody ekspansji ex vivo limfocytó…
|
Polish | 818 bytes | ||
| 2025-11-07 09:11 |
Board/Management Information
Powołanie do Rady Dyrektorów Immuthera C-corp renomowanego naukowca i lidera br…
|
Polish | 1.7 KB | ||
| 2025-10-31 13:04 |
Major Shareholding Notification
Formularz
|
Polish | 789.9 KB | ||
| 2025-10-31 13:04 |
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienie od TFI Allianz Polska S.A. o zmianie udziału w ogólnej liczby gło…
|
Polish | 502 bytes | ||
| 2025-09-10 17:09 |
Audit Report / Information
Raport biegłego rewidenta z przeglądu sprawozdania finansowego
|
Polish | 233.4 KB | ||
| 2025-09-10 17:09 |
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności za okres 6 miesięcy zakończony dnia 30 czer…
|
Polish | 2.8 MB | ||
| 2025-09-10 17:09 |
Interim Report
Sprawozdanie finansowe za okres 6 miesięcy zakończony dnia 30 czerwca 2025 roku
|
Polish | 3.4 MB | ||
| 2025-09-03 10:39 |
Regulatory News Service
Warunkowe przyznanie patentu przez Koreański Urząd Patentowy w projekcie terapi…
|
Polish | 1.7 KB | ||
| 2025-08-04 14:37 |
Legal Proceedings Report
Podanie pierwszemu pacjentowi terapii w ramach badania klinicznego fazy II w pr…
|
Polish | 2.8 KB | ||
| 2025-07-31 08:50 |
Legal Proceedings Report
Otrzymanie od FDA protokołu z podsumowaniem spotkania pre-IND - Content (PL)
|
Polish | 2.0 KB | ||
| 2025-07-29 14:05 |
Regulatory News Service
Otrzymanie Certyfikatu Dobrej Praktyki Wytwarzania od Głównego Inspektora Farma…
|
Polish | 1005 bytes | ||
| 2025-06-23 15:30 |
Regulatory News Service
Warunkowe przyznanie europejskiego patentu dotyczącego metody ekspansji ex vivo…
|
Polish | 884 bytes | ||
| 2025-06-13 15:56 |
Foreign Filer Report
Rejestracja spółki zależnej Immuthera w USA - Content (PL)
|
Polish | 784 bytes | ||
| 2025-05-21 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Zgromadze…
|
Polish | 2.3 KB |
Automate Your Workflow. Get a real-time feed of all Poltreg S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Poltreg S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Poltreg S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
